Agalloco James, Tidswell Edward C
Agalloco & Associates Inc. Belle Mead, NJ, USA; and
Merck & Co. Inc., West Point, PA, USA.
PDA J Pharm Sci Technol. 2018 Nov-Dec;72(6):566-573. doi: 10.5731/pdajpst.2017.008532. Epub 2018 Jun 27.
The terminal sterilization of drugs and devices is the most appropriate means of assuring patient safety in terms of infection prevention. Adoption of terminal sterilization processes requires a supporting and thorough program for control and monitoring of bioburden, especially if a parametric release program of sterilization is desired. Such a control program should necessarily assess and evaluate the associated bioburden (primarily spores), which may resist inactivation and challenge the sterilization cycle. The bioburden resistance can be evaluated by several means and procedures (e.g., the boil test); however, these procedures should be designed and implemented taking into consideration the nature of the spore and spore recovery. This short review describes the application of moist heat resistance for the terminal sterilization of drugs. The terminal sterilization of drugs and devices is the most appropriate means of assuring patient safety in terms of infection prevention. Adoption of terminal sterilization processes requires a supporting and thorough program for control and monitoring of bioburden, especially if a parametric release program of sterilization is desired. This short review describes the application of moist heat resistance for the terminal sterilization of drugs.
药品和器械的最终灭菌是预防感染、确保患者安全的最恰当手段。采用最终灭菌工艺需要一个全面且配套的生物负荷控制与监测计划,尤其是在期望实施灭菌参数放行程序时。这样一个控制计划必须评估和评价相关的生物负荷(主要是孢子),这些孢子可能抵抗灭活并对灭菌周期构成挑战。生物负荷抗性可以通过多种方法和程序来评估(例如煮沸试验);然而,设计和实施这些程序时应考虑孢子的性质和孢子回收情况。本简短综述描述了湿热抗性在药品最终灭菌中的应用。药品和器械的最终灭菌是预防感染、确保患者安全的最恰当手段。采用最终灭菌工艺需要一个全面且配套的生物负荷控制与监测计划,尤其是在期望实施灭菌参数放行程序时。本简短综述描述了湿热抗性在药品最终灭菌中的应用。